People: NMT Medical Inc (NMTI.O)

NMTI.O on Consolidated Issue listed on NASDAQ Capital Market

--USD
--
Price Change (% chg)

-- (--)
Prev Close
$2.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,164
52-wk High
$2.87
52-wk Low
$0.60

view people for:

Summary

Name Age Since Current Position
Mahoney, James 66 2008 Chairman of the Board
Martin, Francis 72 2009 President, Chief Executive Officer, Director
Davis, Richard 51 2009 Chief Financial Officer, Chief Operating Officer, Corporate Secretary, Director
Clarkson, Cheryl 56 2001 Director
Hanley, Daniel 59 2003 Director
West, David 62 2007 Director
» Insider Trading

Biographies

Name Description
Mahoney, James Mr. James J. Mahoney, Jr. is Chairman of the Board of NMT Medical Inc. He is Director of the Company in October 2007 by Board, and named Chairman of the Board in January 2008. Mr. Mahoney currently serves as President of the Mahoney Group, a private financial consulting firm, which he founded in 2004. Prior to founding the Mahoney Group, he co-founded the venture capital and equity investment firm HLM Management Company, where he spent 20 years working with portfolio companies in technology, health care services, medical technology and business services. Mr. Mahoney’s prior experience includes serving as general partner for Cowen & Company and as a securities analyst at Keystone Custodian Funds. Mr. Mahoney began his career in finance at Touche Ross & Company. Mr. Mahoney currently serves as the Lead Director of Aspect Medical Systems. He served as Chairman of the Board of Directors of PolyMedica Corporation (NASDAQ: PLMD) from 2005 to 2007 until PolyMedica’s acquisition by Medco Health Solutions (NYSE:MHS) in October 2007. Mr. Mahoney also serves as a board member for two privately held companies and as an advisor to five investment firms and endowment funds, and as a trustee of Blessed John XXIII National Seminary.
Martin, Francis Mr. Francis Martin is President, Chief Executive Officer, Director of NMT Medical Inc. He is Director of the Company in February 2001 and since February 2009 has been serving as President and Chief Executive Officer. From March 2007 through October 2008, Mr. Martin served as the Chief Executive Officer of Corindus Inc., a company that designs, manufactures and commercializes remote control systems for interventional cardiology. From October 2005 until March 2007, Mr. Martin was Executive Chairman of Cappella Inc., a medical device company that develops coronary stents. From September 2004 to October 2005, Mr. Martin was an independent consultant and advisor to global venture capital firms, corporations and entrepreneurs in the medical technology industry. From October 2000 to March 2005, Mr. Martin was the Chairman and Chief Executive Officer of Florence Medical LTD, which developed and marketed vascular blood flow software and hardware systems used to assist the interventional cardiologist in the diagnosis and treatment of vascular disease. From June 1993 to June 2000, he was founder, Chairman and Chief Executive Officer of CorMedica Corporation, a private, independent developer and manufacturer of catheter-based navigation systems for use in percutaneous cardiovascular applications. Mr. Martin has an extensive background in the medical device industry, having co-founded and managed Advanced Biomedical Instruments from 1979 to 1986 and PLC Systems from 1987 to 1993. Prior to that, Mr. Martin was with Becton Dickinson & Co. and Abbott Laboratories, where he held senior management positions, domestically and internationally, in marketing, sales and business development. Mr. Martin is a board member of several privately-held companies.
Davis, Richard Mr. Richard E. Davis has been appointed as Chief Financial Officer, Chief Operating Officer, Corporate Secretary, Director of NMT Medical, Inc effective June 24, 2009. Mr. Davis has served as NMT's Chief Financial Officer and Corporate Secretary since February 2001 and was promoted to Chief Operating Officer in February 2009. From August 2000 to February 2001, Mr. Davis served as the Interim Chief Financial Officer through his employment with the consulting firm of Argus Management Corporation. From July 1998 to July 2000, Mr. Davis was Vice President and Chief Financial Officer of Q-Peak, Inc., a marketer and manufacturer of solid-state laser systems. Prior to July 1998, Mr. Davis served in various senior financial management positions at TJX Companies, Inc. for 10 years.
Clarkson, Cheryl Ms. Cheryl L. Clarkson is Director of NMT Medical Inc since January 2001. Since 1999, Ms. Clarkson has served as the President and Chief Executive Officer of SkinHealth, Inc., a physician-based cosmetic dermatology company that Ms. Clarkson founded and that operates SkinHealth Centers throughout eastern New England. Ms. Clarkson has previously served as the acting Chief Executive Officer and the Chief Operating Officer of Peer Review Analysis, Inc., a publicly-traded health care adjudication and utilization review company, the President of ABIODENT, Inc., Danvers, Massachusetts, a dental device company, and the President of Beaver Steriseal, Inc., an ophthalmic surgical device company. Ms. Clarkson has also been the Vice President of Sales and Marketing for Rudolph Beaver, Inc., and spent ten years with American Hospital Supply Corporation in various management positions. She holds a Masters degree from the Sloan School of Management at M.I.T., where she was selected as a Sloan fellow. Ms. Clarkson serves as an overseer for a large teaching hospital.
Hanley, Daniel Mr. Daniel F. Hanley, M.D. is Director of NMT Medical Inc since May 2003. Since 1996, Dr. Hanley has been a Professor of Neurology, Neurosurgery and Anesthesia/Critical Medicine at Johns Hopkins Medical Institutions. Since 1999, Dr. Hanley has also been Professor, School of Nursing; he is the Jeffrey and Harriett Legum Chair of Acute Care Neurology and Director of Brain Injury Outcomes Program at Johns Hopkins Medical Institutions. Dr. Hanley is a graduate of Williams College and Cornell University Medical College and has board certification in internal medicine, neurology and psychiatry. Dr. Hanley is a leading expert on multiple types of brain injury and brain injury recovery. He has received more than 40 clinical and basic research grants, predominately from the National Institute of Health and the FDA Orphan drugs program. He has published more than 150 articles in peer-reviewed journals, has received the Alexander Humboldt International Research Prize for his accomplishments in brain injury research and has extensive clinical trials experience in that field. His trainees are directors of over 20 brain intensive care units across the United States. Dr. Hanley is the Vice Chairman of the Board of Directors of the National Stroke Association and has developed nationally recognized education and training programs for that organization. He has significant business experience in the areas of clinical trials design, organization and interpretation, drug development, device development and regulatory compliance.
West, David Mr. David L. West, Ph.D., M.P.H. is Director of NMT Medical Inc since July 2007 by the board of directors. Dr. West is a Vice President of Quintiles Consulting, where he has been employed since 1994, assisting domestic and international medical device companies in developing and implementing strategic and regulatory plans for medical devices and combination products. From 1989 to 1993 Dr. West was Deputy Director of the Office of Device Evaluation, Center for Devices and Radiological Health, FDA. Dr. West is a expert in medical device laws and regulation, medical device development and evaluation, regulatory strategy and policy formulation, and device/drug/biologic combination products.

Basic Compensation

Name Fiscal Year Total
Mahoney, James --
Martin, Francis --
Davis, Richard 415,520
Clarkson, Cheryl --
Hanley, Daniel --
West, David --
As Of 30 Dec 2008

Options Compensation

Name Options Value
Mahoney, James 0 0
Martin, Francis 0 0
Davis, Richard 172,229 1,695,413
Clarkson, Cheryl 0 0
Hanley, Daniel 0 0
West, David 0 0

Insider Trading

Name Shares Traded Price
CLARKSON CHERYL L 10,000 $2.25
MAHONEY JAMES J JR 12,222 $2.25
MARTIN FRANCIS J 4,048 $2.25
DAVIS RICHARD E 5,532 $2.25
HANLEY DANIEL F 9,333 $2.25
DAVIS RICHARD E 2,500 $1.60
DAVIS RICHARD E 500 $1.60
MARTIN FRANCIS J 4,633 $1.81
MARTIN FRANCIS J 1,367 $1.71
DAVIS RICHARD E 8,200 $1.72
CLARKSON CHERYL L 4,651 $1.72
MAHONEY JAMES J JR 7,267 $1.72
KREVLIN ADVISORS L L C 10,000 $2.37
KREVLIN ADVISORS L L C 10,000 $2.47
KREVLIN ADVISORS L L C 10,000 $2.14
KREVLIN ADVISORS L L C 10,000 $2.09
KREVLIN ADVISORS L L C 10,000 $2.05
KREVLIN ADVISORS L L C 10,000 $1.96
CLARKSON CHERYL L 1,000 $2.03
KREVLIN ADVISORS L L C 10,000 $2.07
KREVLIN ADVISORS L L C 10,000 $2.06
CLARKSON CHERYL L 100 $1.90
CLARKSON CHERYL L 1,000 $1.90
KREVLIN ADVISORS L L C 10,000 $2.00
CLARKSON CHERYL L 1,000 $1.92
» Full list on Insider Trading
view people for: